Baillie Gifford & Co’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $232M | Sell |
12,066,479
-244,410
| -2% | -$4.86M | 0.24% | 85 |
|
|
2025
Q4 | $203M | Buy |
12,310,889
+719,304
| +6% | +$12.1M | 0.17% | 102 |
|
|
2025
Q3 | $168M | Sell |
11,591,585
-363,738
| -3% | -$5.23M | 0.12% | 107 |
|
|
2025
Q2 | $167M | Sell |
11,955,323
-134,717
| -1% | -$1.9M | 0.12% | 106 |
|
|
2025
Q1 | $164M | Sell |
12,090,040
-223,891
| -2% | -$4.29M | 0.14% | 108 |
|
|
2024
Q4 | $251M | Sell |
12,313,931
-1,031,956
| -8% | -$26.4M | 0.19% | 84 |
|
|
2024
Q3 | $389M | Sell |
13,345,887
-417,709
| -3% | -$10.4M | 0.29% | 68 |
|
|
2024
Q2 | $320M | Sell |
13,763,596
-277,632
| -2% | -$5.33M | 0.25% | 77 |
|
|
2024
Q1 | $288M | Sell |
14,041,228
-219,496
| -2% | -$4.13M | 0.22% | 83 |
|
|
2023
Q4 | $306M | Sell |
14,260,724
-420,303
| -3% | -$8.32M | 0.24% | 83 |
|
|
2023
Q3 | $303M | Sell |
14,681,027
-162,743
| -1% | -$4.13M | 0.28% | 76 |
|
|
2023
Q2 | $438M | Sell |
14,843,770
-508,341
| -3% | -$14.3M | 0.37% | 61 |
|
|
2023
Q1 | $354M | Buy |
15,352,111
+232,637
| +2% | +$6.4M | 0.32% | 71 |
|
|
2022
Q4 | $420M | Buy |
15,119,474
+404,423
| +3% | +$12M | 0.44% | 63 |
|
|
2022
Q3 | $452M | Sell |
14,715,051
-154,323
| -1% | -$5.02M | 0.47% | 56 |
|
|
2022
Q2 | $438M | Sell |
14,869,374
-111,058
| -0.7% | -$2.91M | 0.45% | 65 |
|
|
2022
Q1 | $482M | Sell |
14,980,432
-75,949
| -0.5% | -$2.61M | 0.34% | 71 |
|
|
2021
Q4 | $672M | Buy |
15,056,381
+46,565
| +0.3% | +$2.21M | 0.37% | 69 |
|
|
2021
Q3 | $757M | Sell |
15,009,816
-137,797
| -0.9% | -$7.77M | 0.4% | 66 |
|
|
2021
Q2 | $1.19B | Buy |
15,147,613
+2,152,416
| +17% | +$133M | 0.58% | 43 |
|
|
2021
Q1 | $742M | Buy |
12,995,197
+804,941
| +7% | +$53.9M | 0.42% | 61 |
|
|
2020
Q4 | $1.02B | Buy |
12,190,256
+1,363,078
| +13% | +$82.4M | 0.57% | 41 |
|
|
2020
Q3 | $388M | Buy |
10,827,178
+1,547,984
| +17% | +$46.6M | 0.27% | 71 |
|
|
2020
Q2 | $224M | Buy |
9,279,194
+149,442
| +2% | +$3.51M | 0.17% | 93 |
|
|
2020
Q1 | $160M | Buy |
9,129,752
+1,539,505
| +20% | +$32.1M | 0.17% | 88 |
|
|
2019
Q4 | $132M | Buy |
7,590,247
+226,784
| +3% | +$3.78M | 0.13% | 100 |
|
|
2019
Q3 | $113M | Sell |
7,363,463
-43,766
| -0.6% | -$836K | 0.13% | 99 |
|
|
2019
Q2 | $154M | Buy |
7,407,229
+1,145,003
| +18% | +$25.7M | 0.16% | 93 |
|
|
2019
Q1 | $145M | Buy |
6,262,226
+34,502
| +0.6% | +$722K | 0.16% | 89 |
|
|
2018
Q4 | $129M | Buy |
6,227,724
+741,303
| +14% | +$13.4M | 0.17% | 87 |
|
|
2018
Q3 | $119M | Buy |
5,486,421
+141,788
| +3% | +$2.35M | 0.13% | 88 |
|
|
2018
Q2 | $81.5M | Buy |
5,344,633
+151,787
| +3% | +$2.86M | 0.09% | 96 |
|
|
2018
Q1 | $102M | Buy |
5,192,846
+271,063
| +6% | +$5.57M | 0.12% | 85 |
|
|
2017
Q4 | $77M | Buy |
+4,921,783
| New | +$88.5M | 0.1% | 90 |
|
Other funds holding DNLI
VCM
VPM
BBA